Total Payments
$905,623
2024 Payments
$183,668
Companies
20
Transactions
1,240
Medicare Patients
933
Medicare Billing
$142,912
Payment Breakdown by Category
Other$618,488 (68.3%)
Consulting$141,394 (15.6%)
Travel$121,914 (13.5%)
Food & Beverage$23,403 (2.6%)
Education$424.04 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $521,346 | 228 | 57.6% |
| Consulting Fee | $141,394 | 70 | 15.6% |
| Travel and Lodging | $121,914 | 352 | 13.5% |
| Honoraria | $95,892 | 37 | 10.6% |
| Food and Beverage | $23,403 | 546 | 2.6% |
| Compensation for serving as faculty or as a speaker for a medical education program | $1,250 | 1 | 0.1% |
| Education | $424.04 | 6 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| JAZZ PHARMACEUTICALS INC. | $539,088 | 720 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $145,967 | 233 | $0 (2024) |
| Axsome Therapeutics, Inc. | $104,495 | 119 | $0 (2024) |
| Avadel CNS Pharmaceuticals, LLC | $99,550 | 105 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $15,635 | 24 | $0 (2024) |
| Inspire Medical Systems, Inc. | $285.75 | 4 | $0 (2024) |
| Arbor Pharmaceuticals, Inc. | $201.04 | 14 | $0 (2020) |
| ABBVIE INC. | $73.32 | 3 | $0 (2023) |
| UCB, Inc. | $54.76 | 4 | $0 (2018) |
| Lilly USA, LLC | $42.94 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $183,668 | 240 | Avadel CNS Pharmaceuticals, LLC ($61,952) |
| 2023 | $235,278 | 288 | JAZZ PHARMACEUTICALS INC. ($111,064) |
| 2022 | $112,625 | 157 | JAZZ PHARMACEUTICALS INC. ($65,127) |
| 2021 | $108,419 | 127 | JAZZ PHARMACEUTICALS INC. ($80,816) |
| 2020 | $72,138 | 90 | Harmony Biosciences LLC ($39,679) |
| 2019 | $93,102 | 161 | JAZZ PHARMACEUTICALS INC. ($92,765) |
| 2018 | $99,657 | 152 | Jazz Pharmaceuticals Inc. ($99,578) |
| 2017 | $736.02 | 25 | Jazz Pharmaceuticals Inc. ($588.37) |
All Payment Transactions
1,240 individual payment records from CMS Open Payments — Page 1 of 50
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,940.00 | General |
| Category: NEUROLOGY | ||||||
| 12/20/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Honoraria | Cash or cash equivalent | $1,600.00 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 12/18/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $121.86 | General |
| Category: NEUROLOGY | ||||||
| 12/18/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Travel and Lodging | In-kind items and services | $64.45 | General |
| Category: NEUROLOGY | ||||||
| 12/18/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Travel and Lodging | In-kind items and services | $25.33 | General |
| Category: NEUROLOGY | ||||||
| 12/17/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $28.48 | General |
| Category: Narcoplepsy | ||||||
| 12/11/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,940.00 | General |
| Category: NEUROLOGY | ||||||
| 12/11/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,940.00 | General |
| Category: NEUROLOGY | ||||||
| 12/10/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,940.00 | General |
| Category: NEUROLOGY | ||||||
| 12/09/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Insomnia | ||||||
| 12/05/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Honoraria | Cash or cash equivalent | $3,800.00 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 12/05/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Honoraria | Cash or cash equivalent | $1,900.00 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 12/05/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Travel and Lodging | Cash or cash equivalent | $680.16 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 12/05/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Travel and Lodging | In-kind items and services | $604.23 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 12/05/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Travel and Lodging | In-kind items and services | $361.09 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 12/05/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $96.25 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 11/20/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Honoraria | Cash or cash equivalent | $2,800.00 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 11/20/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: Neurology | ||||||
| 11/20/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $109.13 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 11/20/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Travel and Lodging | In-kind items and services | $44.65 | General |
| Category: NEUROLOGY | ||||||
| 11/20/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Travel and Lodging | In-kind items and services | $41.90 | General |
| Category: NEUROLOGY | ||||||
| 11/15/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Consulting Fee | Cash or cash equivalent | $1,470.00 | General |
| Category: NEUROLOGY | ||||||
| 11/15/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Consulting Fee | Cash or cash equivalent | $980.00 | General |
| Category: NEUROLOGY | ||||||
| 11/15/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Consulting Fee | Cash or cash equivalent | $245.00 | General |
| Category: NEUROLOGY | ||||||
| 11/14/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Honoraria | Cash or cash equivalent | $3,800.00 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 242 | 420 | $118,800 | $39,721 |
| 2022 | 5 | 238 | 369 | $108,800 | $37,518 |
| 2021 | 5 | 189 | 300 | $89,425 | $33,843 |
| 2020 | 6 | 264 | 371 | $81,375 | $31,831 |
Total Patients
933
Total Services
1,460
Medicare Billing
$142,912
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2023 | 63 | 154 | $53,900 | $17,618 | 32.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 95 | 149 | $33,525 | $11,340 | 33.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 39 | 39 | $16,575 | $5,316 | 32.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 22 | 35 | $10,500 | $3,895 | 37.1% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 23 | 43 | $4,300 | $1,552 | 36.1% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2022 | 53 | 118 | $41,300 | $14,741 | 35.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 97 | 153 | $34,425 | $11,736 | 34.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 55 | 55 | $23,375 | $7,532 | 32.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 22 | 27 | $8,100 | $2,975 | 36.7% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 11 | 16 | $1,600 | $533.55 | 33.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 60 | 116 | $26,100 | $9,646 | 37.0% |
| 95800 | Study of sleep patterns, including sleep time | Office | 2021 | 31 | 71 | $24,850 | $9,593 | 38.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 46 | 61 | $18,300 | $6,938 | 37.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 41 | 41 | $17,425 | $6,682 | 38.3% |
| 95810 | Sleep monitoring of patient (6 years or older) in sleep lab | Office | 2021 | 11 | 11 | $2,750 | $984.36 | 35.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 138 | 224 | $46,785 | $17,960 | 38.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 45 | 57 | $16,560 | $6,662 | 40.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 42 | 45 | $6,995 | $2,722 | 38.9% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 16 | 16 | $5,735 | $2,246 | 39.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 12 | 12 | $3,720 | $1,530 | 41.1% |
| 99457 | Remote physiologic monitoring treatment management services, health care professional time in a calendar month requiring interactive communication with the patient/caregiver; first 20 minutes | Office | 2020 | 11 | 17 | $1,580 | $711.41 | 45.0% |
About Dr. Gerard Meskill, MD
Dr. Gerard Meskill, MD is a Neurology healthcare provider based in Sugar Land, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/03/2009. The National Provider Identifier (NPI) number assigned to this provider is 1295975324.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gerard Meskill, MD has received a total of $905,623 in payments from pharmaceutical and medical device companies, with $183,668 received in 2024. These payments were reported across 1,240 transactions from 20 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($521,346).
As a Medicare-enrolled provider, Meskill has provided services to 933 Medicare beneficiaries, totaling 1,460 services with total Medicare billing of $142,912. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Sleep Medicine
- Location Sugar Land, TX
- Active Since 03/03/2009
- Last Updated 03/05/2024
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1295975324
Products in Payments
- XYWAV (Drug) $284,912
- SUNOSI (Drug) $119,142
- Sunosi (Drug) $104,495
- Xyrem (Drug) $100,147
- LUMRYZ (Drug) $99,550
- Wakix (Drug) $97,412
- WAKIX (Drug) $45,755
- XYREM (Drug) $34,412
- QUVIVIQ (Drug) $15,635
- Inspire Upper Airway Stimulation System (Device) $243.00
- Horizant (Drug) $174.00
- NURTEC ODT (Drug) $60.19
- Neupro (Drug) $54.76
- UBRELVY (Drug) $43.90
- EMGALITY (Drug) $42.94
- INSPIRE (Device) $42.75
- Aimovig (Biological) $33.59
- QULIPTA (Drug) $29.42
- AirCurve (Device) $27.06
- Edarbi (Drug) $27.04
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Sugar Land
Dr. Toby Yaltho, Md, MD
Neurology — Payments: $248,176
Neurology $248,176
Charles Popeney, D.o, D.O
Neurology — Payments: $107,875
Neurology $107,875
Dr. Larry Tran, Md, MD
Neurology — Payments: $21,060
Neurology $21,060
Jessica Schultz, M.d, M.D
Neurology — Payments: $18,188
Neurology $18,188
Desiree Thomas, Md, MD
Neurology — Payments: $12,794
Neurology $12,794
Muhammad Taimur Malik, M.d, M.D
Neurology — Payments: $9,903
Neurology $9,903